- Home
- LGND vs INSW Comparison
LGND vs INSW Comparison
Compare LGND & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- INSW
- Stock Information
- Founded
- LGND 1987
- INSW 1999
- Country
- LGND United States
- INSW United States
- Employees
- LGND N/A
- INSW N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- INSW Semiconductors
- Sector
- LGND Health Care
- INSW Technology
- Exchange
- LGND Nasdaq
- INSW Nasdaq
- Market Cap
- LGND 2.3B
- INSW 2.0B
- IPO Year
- LGND 1992
- INSW N/A
- Fundamental
- Price
- LGND $111.89
- INSW $38.45
- Analyst Decision
- LGND Strong Buy
- INSW Strong Buy
- Analyst Count
- LGND 6
- INSW 3
- Target Price
- LGND $145.00
- INSW $60.67
- AVG Volume (30 Days)
- LGND 124.3K
- INSW 1.4M
- Earning Date
- LGND 02-25-2025
- INSW 02-27-2025
- Dividend Yield
- LGND N/A
- INSW 15.01%
- EPS Growth
- LGND 160.46
- INSW N/A
- EPS
- LGND 2.47
- INSW 10.33
- Revenue
- LGND $152,422,000.00
- INSW $1,007,734,000.00
- Revenue This Year
- LGND $26.86
- INSW N/A
- Revenue Next Year
- LGND $14.95
- INSW $1.61
- P/E Ratio
- LGND $45.27
- INSW $3.72
- Revenue Growth
- LGND N/A
- INSW N/A
- 52 Week Low
- LGND $67.72
- INSW $32.11
- 52 Week High
- LGND $129.90
- INSW $65.94
- Technical
- Relative Strength Index (RSI)
- LGND 50.22
- INSW 51.17
- Support Level
- LGND $102.79
- INSW $40.30
- Resistance Level
- LGND $112.61
- INSW $41.62
- Average True Range (ATR)
- LGND 4.01
- INSW 1.37
- MACD
- LGND 0.39
- INSW 0.57
- Stochastic Oscillator
- LGND 87.67
- INSW 48.44
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.